Status:
COMPLETED
Follow up of Nasolacrimal Intubation in Adults
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Lacrimal Apparatus Diseases
Dacryocystitis
Eligibility:
All Genders
18-75 years
Brief Summary
For patients with chronic epiphora, Dacryocystorhinostomy is currently the gold standard treatment, with a success rate of 80-90% according to literature. Another available treatment, which is far les...
Detailed Description
Under normal conditions, the amount of tears excreted from lacrimal glands to the eye is equal to the amount drained through the tear duct. Epiphora in adults usually involves a blockage of the lacrim...
Eligibility Criteria
Inclusion
- Clinical diagnosis of mild epiphora.
- Underwent nasolacrimal intubation during 01/2000 - 12/2007.
Exclusion
- Purulent excretions from nasolacrimal duct on day of admission or intubation.
- Nasolacrimal intubation in the past.
- Dacryocystorhinostomy in the past.
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00706251
Start Date
January 1 2000
Last Update
June 27 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maccabi Healthcare Eye Clinic
Tel Aviv, Israel